期刊
CURRENT ONCOLOGY
卷 28, 期 3, 页码 2115-2122出版社
MDPI
DOI: 10.3390/curroncol28030196
关键词
targeted osmotic lysis; advanced-stage cervical cancer; sodium channels; sodium pumps
类别
资金
- Dorothy Dorsett Brown Foundation
- Oleander Medical Technologies
TOL technology, through the stimulation of VGSCs and blocking of sodium pumps, has shown to be an effective and safe treatment for aggressive advanced carcinomas, extending patients' lives without compromising quality of life. This treatment may have broad applications for advanced-stage carcinomas.
Upregulation of voltage-gated sodium channels (VGSCs) and Na+/K+-ATPase (sodium pumps) is common across most malignant carcinomas. Targeted osmotic lysis (TOL) is a developing technology in which the concomitant stimulation of VGSCs and pharmacological blockade of sodium pumps causes rapid selective osmotic lysis of carcinoma cells. This treatment of cervical carcinoma is evidence that TOL is a safe, well-tolerated and effective treatment for aggressive advanced carcinomas that has the potential to extend life without compromising its quality. TOL is likely to have broad application for the treatment of advanced-stage carcinomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据